Abstract
Aim and Objectives
The aim of this study was to evaluate changes in alveolar bone height by means of radiographic examination and Straumann implant survival rate following maxillary sinus lift augmentation using autogenous bone in combination with platelet rich plasma (PRP) versus venous blood (VB).
Methods
Fifty patients requiring sinus lift augmentation procedure included in the study were divided into two groups (n = 25). During the procedure the sub antral sinus cavity was augmented using autogenous bone taken from mandibular ramus area and mixed with PRP in one group and autogenous bone mixed with VB in the other group. Orthopantomograms were taken preoperatively, immediate, at 6 months and 1 year postoperatively. Height of alveolar bone at the site of sinus augmentation was measured on the radiographs. One hundred and twenty-one Straumann dental implants were placed after healing period.
Results
Age of the patients in the study groups ranged from 36 to 69 years. Differences in mean values of bone height measurements recorded in the PRP series revealed significant differences among the three subgroups (P = 0.001). Significant differences were noted between immediate postop and 6 month (P < 0.01), immediate postop and year (P < 0.01). In the VB series also significant differences were revealed among the three subgroups (P = 0.0280). Significant differences were noted between immediate postop and 6 month (P < 0.05). Comparison of results of subgroups of the two series at the three intervals revealed significant differences at ‘immediate postop’ values (P = 0.0002) and ‘sixmon’ values (P = 0.0435). Differences between ‘year’ values were not significant. Two implants were lost in PRP group.
Conclusion
The results of this limited study reveals that both groups recorded a good increase in the alveolar bone height after sinus augmentation and showed no significant differences between these groups when compared to each other at 1 year postoperatively. When both sub groups compared with immediate postop to year, PRP group showed significant difference and blood group showed no significant difference.
Keywords: Sinus lift, Platelet rich plasma (PRP), Venous blood, Autogenous bone, Straumann implants
Introduction
Implant placement in the posterior maxilla is always a challenge to the surgeon due to pneumatization of the sinus with age and also due to poor quality of the bone. Success of implant osseointegration always depends on the quality and quantity of bone. The solution offered to counter this problem and for placing dental implants is the raising and augmentation of the maxillary sinus floor, and it is referred to as sinus floor augmentation which was first described by Tatum [1].
A variety of materials have been utilized for maxillary sinus augmentation ranging from bone substitute materials to autogenous bone. Many authors recommend autogenous bone [2, 3] where as some authors recommend heterografts [4–6] and further some others prefer xenografts [7, 8] and synthetic [9, 10] bone substitutes. Some studies by various authors even showed mixing the bone grafts with platelet rich plasma (PRP) [11] and venous blood (VB) [12]. Since PRP and VB is developed from autologous blood, it is safe and free from transmissible diseases. PRP [13–15] is a source of several growth factors, particularly platelet derived growth factor (PDGF), transforming growth factor, vascular endothelial growth factor, insulin like growth factor, epidermal growth factor and other growth factors (Table 1).
Table 1.
PRP group statistical data at all intervals
| Preoperative | Imm-post op | P-six month | P-one year | |
|---|---|---|---|---|
| Mean | 4.76 | 18.73 | 17.15 | 17.28 |
| SEM | 0.24 | 0.23 | 0.34 | 0.32 |
| SD | 1.19 | 1.15 | 1.68 | 1.61 |
The aim of the study was to evaluate changes in alveolar bone height by means of radiographic examination and implant survival rate following maxillary sinus lift augmentation using autogenous bone in combination with PRP and VB.
Materials and Methods
Fifty patients requiring sinus lift augmentation procedure included in the study were divided into two groups (n = 25). During the procedure the sinus cavity was augmented using autogenous bone mixed with PRP in one group and autogenous bone mixed with VB in the other group. Mean age in the PRP group was 51.2 (ranging from 36 to 67 years) and in the VB group it was 55.1 (ranging from 38 to 69 years). In the PRP group there were 21 females and 4 males and in the VB group there were 14 females and 11 males (Table 2).
Table 2.
Venous blood group statistical data at all intervals
| Pre-operative | Imm-post op | P-six month | P-one year | |
|---|---|---|---|---|
| Mean | 4.84 | 17.13 | 16.31 | 16.71 |
| SEM | 0.23 | 0.27 | 0.17 | 0.15 |
| SD | 1.16 | 1.37 | 0.83 | 0.73 |
Pre-operative evaluation included detailed medical, clinical history and radiological examination. All the orthopantomogram radiographs showed inadequate alveolar bone height in the posterior maxilla. Pre-operatively the height of the alveolar bone ranged from 1 to 5 mm and the mean alveolar bone height in PRP group was 4.76 mm and in VB group it was 4.84 mm.
Surgical Procedure
The sinus lift operation for bone augmentation of the posterior maxillae can help to correct the problem of insufficient bone by raising the sinus floor and developing bone for the placement of dental implants (Table 3).
Table 3.
Comparision of statistical data between PRP and VB groups
| Pre operative mean | SEM | Immediate post op mean | SEM | 6 month post op mean | SEM | 1 year post op mean | SEM | |
|---|---|---|---|---|---|---|---|---|
| PRP group | 4.76 | 0.24 | 18.73 | 0.23 | 17.15 | 0.34 | 17.28 | 0.32 |
| VB group | 4.84 | 0.23 | 17.13 | 0.27 | 16.31 | 0.17 | 16.71 | 0.15 |
The sinus lift surgical procedures were done under intravenous sedation. A crestal (or) palatal incision was placed and mucoperiosteal flap raised and buccal surface of the maxillary sinus was exposed. A 2 cm wide window was made on the lateral wall of the sinus, bone plate was separated from the Schneiderian membrane (Table 4).
Table 4.
Data showing no of Straumann dental implants placed
| Implants placed | Implants lost | |
|---|---|---|
| PRP group | 58 | 2 |
| VB group | 63 | 0 |
| Total | 121 | 2 |
After Schneiderian membrane was elevated using sinus lift instruments, resorbable collagen membrane was placed below the Schneiderian membrane (Fig. 1) and autogenous graft material which was taken from the same side mandibular ramus area was particulated in a bone mill (Fig. 2) and made into small bone slices of 2 mm × 2 mm (Fig. 3) and mixed with PRP (Fig. 4) or with VB (Fig. 5). The autogenous bone mixed with 8 ml of PRP was then packed into the space between the elevated Schneiderian membrane along the collagen membrane and the bony wall and sinus floor for the patients in PRP group.
Fig. 1.

Resorbable collagen membrane placed below sinus membrane
Fig. 2.

Bone graft in bone miller
Fig. 3.

Bone graft made into slices
Fig. 4.

Bone graft mixed with PRP
Fig. 5.

Bone graft mixed with venous blood
For the patients in VB group, the autogenous bone was mixed with 8 ml of the VB sampled from the vein of the patients’ arm and then used to fill the space formed after elevating the Schneiderian membrane. Resorbable collagen membrane was used to cover the prepared window (Fig. 6). Mucoperisteal flap was repositioned and the wound was closed using non-resorabable suture material. After a healing period of 4–6 months the implant placement procedure was done.
Fig. 6.

Resorbable collagen membrane was used to cover the prepared sinus cavity
Patient Evaluation and Follow Up
All the patients in the study were evaluated clinically and radiographically preoperative, immediate postoperative, 6 months and 1 year postoperatively. Clinical assessment was done for any infection, wound dehiscence, sequestration, loss of graft and loss of implants. Alveolar bone height was measured preoperatively, immediate, 6 months and 1 year postoperatively on the orthopantomogram radiograph. The alveolar bone height was measured at three places on the sinus i.e. in the mesial side, central part and in the distal side of the maxillary sinus before and after sinus augmentation. The outline of the maxillary sinus before and after sinus augmentation was reproduced on the tracing paper from the orthopantomogram radiograph and measurements were recorded. All the measurements were added and average of the total was taken as the standard value for the alveolar bone height.
Results
In both groups 14 procedures were carried out on the left side and 11 on right side. Pre-operatively the mean of the alveolar bone height in the PRP group was 4.76 mm and in the VB group it was 4.84 mm. In PRP group 58 Straumann implants were placed, and in VB group 63 Straumann implants were placed after a healing period of 4–6 months after sinus augmentation procedure. Two Straumann implants were lost in the PRP group.
Statistical Analysis
Kruskal–Wallis (non parametric one-way ANOVA) test was conducted to detect differences among the results of the three subgroups of PRP and VB groups in relation to values obtained for the alveolar bone height at immediate postoperative, 6 month and 1 year postoperative periods.
Significant differences were confirmed when the Kruskal–Wallis statistic (KW) was high and the P value approximate from Chi square distribution was <0.05.
When there was a significant difference among the three subgroups as above, Dunn’s post test was carried out to compare the differences among each pair of columns. Significant P value was considered to be <0.05.
Results obtained for the relevant subgroups in PRP and VB were compared using Mann–Whitney test. Significant P value was considered to be <0.05.
ANOVA test comparing the three subgroups (immediate post-operative, 6 months and 1 year post-operative) of PRP group revealed significant differences (P = 0.001, KW statistic = 13.87).
Dunn’s posttest comparing subgroups (immediate post-operative, 6 months and 1 year post-operative) of PRP revealed significant differences between immediate postop and 6 month (P < 0.01), immediate postop and year (P < 0.01). Differences between 6 month and year are not significant.
ANOVA test comparing the three subgroups(immediate post-operative, 6 months and 1 year post-operative) of VB group revealed significant differences (P = 0.0280, KW statistic = 7.152).
Dunn’s posttest comparing subgroups(immediate post-operative, 6 months and 1 year post-operative) of VB group reveals significant differences between immediate postop and 6 month (P < 0.05).
Differences between immediate postop and year and also 6 month and year are not significant in VB group.
Mann–Whitney test revealed significant differences between immediate postop subgroups of PRP and VB groups (P = 0.0002).
Mann–Whitney test revealed significant differences between 6 month subgroups of PRP and VB groups (P = 0.0435).
Mann–Whitney test revealed differences between year subgroups of PRP and VB groups as not significant.
Disscussion
In 1994, Tayapongsak et al. [16] introduced the idea of adding autologous fibrin adhesive to cancellous bone during mandibular reconstruction. Marx et al. [17] have shown that the use of PRP concentrate was a source of autologous growth factors and led to an increase in the bone formation and density after autologous bone grafting.
Kim et al. [18], suggested the use of PRP in treatment of bone defects around implants and showed good results in accelerating the osseointegration of titanium implants. In 2001, Yildirium et al. [19] evaluated the bone formation following maxillary sinus augmentation using bovine substitute material bio-oss in combination with VB by means of histologic and histomorphometric examination of human biopsies and histomorphometric examination of human biopsies and the analysis showed 14.7 % newly formed bone and 29.1 % of the surface of the bio-oss granulate was in direct contact with newly formed bone. Study by Lundgren et al. [20] indicated that bone grafts or bone substitutes may not be needed to achieve augmentation of the maxillary sinus floor. McCarthy et al. [21] conducted a study and evaluated that sinus augmentation procedure using autogenous bone grafting can increase bone volume to allow implant placement where there is insufficient bone and infection during the healing of the grafted site which reduces the success of subsequent implant osseointegration. A clinical study by Thor et al. [22] showed that high implant survival rate was achieved after 1 year of loading in the maxillae following autogenous bone grafting whether or not PRP was used, with less bone resorption on PRP side.
Raghobear et al. [23] in 2005 showed that the PRP had no beneficial effect on wound healing and bone remodeling of autogenous bone grafts used for augmentation of the maxillary sinus floor. Choukroun et al. [24] showed that sinus floor augmentation with FDBA and platelet-rich fibrin leads to a reduction of healing time prior to implant placement.
In the present study Krusal–Wallis test was used to compare the results of the three sub groups of PRP and VB groups at immediate post-operative, 6 months and 1 year post-operatively. Mann–Whitney test was used to compare between PRP and VB groups.
In the PRP group, mean value of immediate post-operative data was 18.73 mm, mean value of 6 moths post-operative was 17.15 mm and 1 year post-operative data showed the mean value to be 17.28 mm.
In the VB group the mean value of immediate post-operative data was 17.13 mm, 6 months post-operative mean value was 16.31 mm and 1 year post-operative data showed the mean value to be 16.71 mm.
Thus this study shows that there is slight graft resorption in both the PRP and VB groups when immediate post-operative data was compared to 6 months data where as when compared to 1 year data PRP group data showed slightly significant difference, but VB group showed no significant difference when immediate data was compared to 1 year data, thus indicating further studies are needed to assess the use of VB as an alternative to PRP.
The advantages of using the autogenous bone mixed with VB are (1) not a time consuming procedure (2) no anticoagulants used (3) reduces the cost (4) no specific device required, (5) can be used in all countries, (6) no chance of infection.
But when these two groups compared among themselves, they show no significant difference after 1 year, showing good clinical benefits in both groups. Implant survival rate in the PRP group was 96.6 % and in the VB group it was 100 %. Two Straumann implants were lost in the PRP group with a failure rate of 3.4 %.
Conclusions
The results of this limited study reveals that both groups recorded a good increase in the alveolar bone height after sinus augmentation and showed no significant differences between the groups when compared to each other at 1 year post-operatively.
Thus the study shows that autogenous bone mixed with PRP or VB produces similar long term clinical results with autologous bone mixed with VB having slight advantage.
Even though there are studies which are providing evidence that the use of autologous PRP does accelerate soft and hard tissue healing in at least limited number of applications further controlled clinical studies with larger sample sizes are needed to evaluate the influence of different parameters on treatment outcome. In addition, defined clinical protocols in combination with long term clinical documentation are needed to identify the clinical benefits for the use of VB in combination with autogenous bone grafts for maxillary sinus augmentation procedures.
Acknowledgments
The authors thank Prof Kanichi Seto of Tsurumi university for his guidace and Dr Jayantha Weerashinge of Peradeneiya University, Srilanka for help with statistical analysis and documentation.
Contributor Information
Namineni Kiran Kumar, Email: drnamineni@yahoo.com.
Mahaboob Shaik, Email: 786maxfac@gmail.com, Email: dr.shaik786@yahoo.co.in.
Balakrishna Manohar Chintapalli, Email: manohar.chintapalli@gmail.com.
References
- 1.Tatum OH. Maxillary and sinus implant reconstructions. Dent Clin North Am. 1986;30:207–229. [PubMed] [Google Scholar]
- 2.Block MS, Kent JN. Sinus augmentation for dental implants. The use of autogenous bone. J Oral Maxillofac Surg. 1997;55:1281–1286. doi: 10.1016/S0278-2391(97)90185-3. [DOI] [PubMed] [Google Scholar]
- 3.Van den Bergh JP, Ten Bruggenkate CM, Krekelar G, et al. Sinus floor elevation and grafting with autogenous iliac crest bone. Clin Oral Implants Res. 1998;9:49–53. doi: 10.1034/j.1600-0501.1996.090608.x. [DOI] [PubMed] [Google Scholar]
- 4.Scher EL, Day RB, Speight PM. New bone formation after sinus lift procedures using demineralized freeze dried bone and tricalcium phosphate. Implant Dent. 1999;8:49–53. doi: 10.1097/00008505-199901000-00005. [DOI] [PubMed] [Google Scholar]
- 5.Grageda E, Lozada JL, Boyne PJ, et al. Bone formation in the maxillary sinus by using platelet-rich plasma: an experimental study in sheep. J Oral Implantol. 2005;1:2–17. doi: 10.1563/0-692.1. [DOI] [PubMed] [Google Scholar]
- 6.Kassolis JD, Reynolds MA. Evaluation of the adjunctive benefits of platelet-rich plasma in subantral sinus augmentation. J Craniofac Surg. 2005;16(2):280–287. doi: 10.1097/00001665-200503000-00015. [DOI] [PubMed] [Google Scholar]
- 7.Piatelli M, Favero GA, Scarano A, et al. Bone reactions to anorganic bovine bone (Bio-Oss) used in sinus augmentation procedures: a histologic long term report of 20 cases in humans. Int J Oral Maxillofac Implants. 1999;14:835–840. [PubMed] [Google Scholar]
- 8.Phillippart P, Daubie V, Pochet R. Sinus grafting using recombinant human tissue factor, platelet rich plasma gel, autologous bone and anorganic bovine bone mineral xenograft: histologic analysis and case reports. Int J Oral Maxillofac Implants. 2005;20:274–281. [PubMed] [Google Scholar]
- 9.Szabo G, Suba Z, Hrabak K, et al. Autogenous bone versus beta-tricalcium phosphate graft alone for bilateral sinus elevations (2-and 3-dimensional computed tomographic, histologic and histomorphometric evaluations): preliminary results. Int J Oral Maxillofac Implants. 2001;16:681–692. [PubMed] [Google Scholar]
- 10.Wiltfang J, Schlegel KA, Schultze-Mosgau S, et al. Sinus floor augmentation with β-tricalciumphosphate (β-TCP): does platelet-rich plasma promote its osseous integration and degradation. Clin Oral Implants Res. 2003;14:213–218. doi: 10.1034/j.1600-0501.2003.140212.x. [DOI] [PubMed] [Google Scholar]
- 11.Mazor Z, Peleg M, Garg AK, Luboshitz J. Platelet-rich plasma for bone graft enhancement in sinus floor augmentation with simultaneous implant placement: patient series study. Implant Dent. 2004;13:65–70. doi: 10.1097/01.ID.0000116454.97671.40. [DOI] [PubMed] [Google Scholar]
- 12.Steigmann M, Garg AK. A comparative study of bilateral sinus lifts performed with platelet-rich plasma alone versus alloplastic graft material reconstituted with blood. Implant Dent. 2005;14:261–265. doi: 10.1097/01.id.0000177412.84225.05. [DOI] [PubMed] [Google Scholar]
- 13.Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:489–496. doi: 10.1016/j.joms.2003.12.003. [DOI] [PubMed] [Google Scholar]
- 14.Pietrak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16:1043–1054. doi: 10.1097/01.scs.0000186454.07097.bf. [DOI] [PubMed] [Google Scholar]
- 15.Tischler M. Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts. N Y State dent J. 2002;68:22–24. [PubMed] [Google Scholar]
- 16.Tayapongsak P, O’Brien DA, Monteiro CB, et al. Autologous fibrin adhesive in mandibular reconstruction with particulate cancellous bone and marrow. J Oral Maxillofac Surg. 1994;52:161–165. doi: 10.1016/0278-2391(94)90401-4. [DOI] [PubMed] [Google Scholar]
- 17.Marx RE, Carlson ER, Eichstaedt RM, Strauss JE, Georgeeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638–646. doi: 10.1016/S1079-2104(98)90029-4. [DOI] [PubMed] [Google Scholar]
- 18.Kim SG, Chung CH, et al. Use of particulate dentin-plaster of Paris combination with/without platelet-rich plasma in the treatment of bone defects around implants. Int J Oral Maxillofac Implants. 2002;17:86–94. [PubMed] [Google Scholar]
- 19.Yildirim M, Spiekermann H, Biesterfeld S, Edelhoff D. Maxillary sinus augmentation using xenogenic bone substitute material bio-oss in combination with venous blood. A histologic and histomorphometric study in humans. Clin Oral Implants Res. 2000;11:217–229. doi: 10.1034/j.1600-0501.2000.011003217.x. [DOI] [PubMed] [Google Scholar]
- 20.Lundgren S, Andersson S, Gualini F, Sennerby L. Bone reformation with sinus membrane elevation: a new surgical technique for maxillary sinus floor augmentation. Clin Implant Dent Relat Res. 2004;6:165–173. doi: 10.1111/j.1708-8208.2004.tb00224.x. [DOI] [PubMed] [Google Scholar]
- 21.McCarthy C, Patel RR, Wragg PF, Brook IM. Sinus augmentation bone grafts for the provision of dental implants: report of clinical outcome. Int J Oral Maxillofac Implants. 2003;18:377–382. [PubMed] [Google Scholar]
- 22.Thor A, Wannfors K, Sennerby L, Rasmusson L. Reconstruction of the severely resorbed maxilla with autogenous bone, platelet-rich plasma, and implants; 1-year results of a controlled prospective 5-year study. Clin Implant Dent Relat Res. 2005;7:209–220. doi: 10.1111/j.1708-8208.2005.tb00066.x. [DOI] [PubMed] [Google Scholar]
- 23.Raghoebar GM, Schortinghuis J, Liem RS, et al. Does platelet-rich plasma promote remodeling of autologous bone grafts used for augmentation of the maxillary sinus floor? Clin Oral Implants Res. 2005;16:349–356. doi: 10.1111/j.1600-0501.2005.01115.x. [DOI] [PubMed] [Google Scholar]
- 24.Choukroun J, Diss A, Simonpieri A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:299–303. doi: 10.1016/j.tripleo.2005.07.012. [DOI] [PubMed] [Google Scholar]
